EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

A rare rosuvastatin–clarithromycin interaction presenting with acute liver injury and delayed rhabdomyolysis

Nithin Tumkur Prasad

Indian Journal of Pharmacology · 2026

DOI: 10.4103/ijp.ijp_96_26 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Indian Journal of Pharmacology, 2026. Verfasst von Nithin Tumkur Prasad. Beteiligte Einrichtung: Department of Internal Medicine, Apollo Specialty Hospital, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Rhabdomyolysis, Clarithromycin, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rosuvastatin, a hydrophilic statin, is generally considered to have a low risk of clinically significant interactions with macrolide antibiotics, and concurrent use with clarithromycin is not contraindicated according to NHS Specialist Pharmacy Service guidance. However, rare cases of severe toxicity have been reported, particularly in the elderly or critically ill patients. A 69-year-old male, with a past medical history of ischemic heart disease developed marked transaminase elevation followed by severe rhabdomyolysis after receiving high-dose rosuvastatin concurrently with clarithromycin for a lower respiratory tract infection. Withdrawal of both agents, along with supportive treatment with intravenous N-acetylcysteine and ursodeoxycholic acid led to a rapid biochemical improvement. The patient subsequently died due to refractory shock related to his critical illness, and death was not directly attributed to the suspected drug–drug interaction. This case highlights a rare but clinically important interaction between rosuvastatin and macrolides that may be under-recognized, particularly in the elderly or critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rosuvastatin CalciumRhabdomyolysisClarithromycinChemical and Drug Induced Liver InjuryAnti-Bacterial AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHumansDrug InteractionsMaleAgedFatal Outcome

Stichwörter der Autor:innen

Acute liver injuryadverse drug reactionclarithromycindrug-drug interactionrhabdomyolysisrosuvastatin

Substanzen

Rosuvastatin CalciumClarithromycinAnti-Bacterial AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Apollo Specialty Hospital, Bengaluru, Karnataka, India.

Zitieren

APA

Prasad, N. T. (2026). A rare rosuvastatin–clarithromycin interaction presenting with acute liver injury and delayed rhabdomyolysis. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_96_26

Vancouver

Prasad NT. A rare rosuvastatin–clarithromycin interaction presenting with acute liver injury and delayed rhabdomyolysis. Indian Journal of Pharmacology. 2026. doi:10.4103/ijp.ijp_96_26

BibTeX
@article{Prasad2026,
  author = {Prasad, Nithin Tumkur},
  title = {A rare rosuvastatin–clarithromycin interaction presenting with acute liver injury and delayed rhabdomyolysis},
  journal = {Indian Journal of Pharmacology},
  year = {2026},
  doi = {10.4103/ijp.ijp_96_26}
}
Kostenlos starten →